Gender Specific Differences in Ankylosing Spondylitis at Treatment Initiation in Patients Treated with Infliximab or Golimumab

被引：0
|
作者：
Starr, Michael [1 ]
Zummer, Michel [2 ]
Choquette, Denis [3 ]
Haraoui, Boulos [3 ]
Rahman, Proton [4 ]
Jones, Henry [6 ]
Sheriff, Maqbool [5 ]
Rampakakis, Emmanouil [7 ]
Psaradellis, Eliofotisti [8 ]
Osborne, Brendan [9 ]
Lehman, Allen [9 ]
Maslova, Karina [9 ]
Nantel, Francois [9 ]
Tkaczyk, Cathy [9 ]
机构：
[1] McGill, Montreal, PQ, Canada
[2] Univ Montreal, Dept Med, Montreal, PQ, Canada
[3] Inst Rhumatol Montreal, Montreal, PQ, Canada
[4] Mem Univ, St John, NF, Canada
[5] Nanaimo Reg Hosp, Nanaimo, BC, Canada
[6] 124th St Med Clin, Edmonton, AB, Canada
[7] JSS Med Res, Montreal, PQ, Canada
[8] JSS Med Res, St Laurent, PQ, Canada
[9] Janssen Inc, Toronto, ON, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2016年 / 43卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
82
引用
收藏
页码：1184 / 1184
页数：1
相关论文
共 50 条
  • [41] Vitiligo improvement in a patient with Ankylosing spondylitis treated with infliximab
    Simon, J. -Abraham
    Burgos-Vargas, Ruben
    DERMATOLOGY, 2008, 216 (03) : 234 - 235
  • [42] Phlegmonous gastritis in an ankylosing spondylitis patient treated with infliximab
    Kim, Bo Young
    Kim, Hyun-Sook
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (05): : 945 - 946
  • [43] Infliximab treatment in ankylosing spondylitis: an observational study
    Nikas, SN
    Alamanos, Y
    Voulgari, PV
    Pliakou, XI
    Papadopoulos, CG
    Drosos, AA
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (06) : 940 - 942
  • [44] Infliximab in the treatment of active and severe ankylosing spondylitis
    Brandt, J
    Sieper, J
    Braun, J
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (06) : S106 - S110
  • [45] Bisphosphonates vs Infliximab in Ankylosing Spondylitis Treatment
    Lunzer, R.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2014, 21 (01): : 38 - 38
  • [46] Bisphosphonates vs infliximab in ankylosing spondylitis treatment
    Viapiana, Ombretta
    Gatti, Davide
    Idolazzi, Luca
    Fracassi, Elena
    Adami, Silvano
    Troplini, Sonila
    Povino, Maria Rosaria
    Rossini, Maurizio
    RHEUMATOLOGY, 2014, 53 (01) : 90 - 94
  • [47] BISPHOSPHONATES VERSUS INFLIXIMAB IN ANKYLOSING SPONDYLITIS TREATMENT
    Viapiana, O.
    Fracassi, E.
    Caimmi, C.
    Idolazzi, L.
    Dartizio, C.
    Zampieri, R.
    Montanari, I.
    Troplini, S.
    Povino, M. R.
    Orsolini, G.
    Gatti, D.
    Rossini, M.
    Adami, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 946 - 946
  • [48] Profiles of Switches in Patient with Ankylosing Spondylitis: Comparing Adalimumab, Etanercept, Infliximab, Golimumab and Certolizumab
    Choquette, Denis
    Bessette, Louis
    Raynauld, Jean-Pierre
    Pelletier, Jean-Pierre
    Haraoui, Boulos
    Villeneuve, Edith
    Massicotte, Frederic
    Remillard, Marie-Anais
    Sauvageau, Diane
    Coupal, Louis
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1345 - 1345
  • [49] Clinical and imaging correlates of response to treatment with infliximab in patients with ankylosing spondylitis
    Stone, M
    Salonen, D
    Lax, M
    Payne, U
    Lapp, V
    Inman, R
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (07) : 1605 - 1614
  • [50] Antiphospholipid and antinuclear antibodies following infliximab treatment in patients with ankylosing spondylitis
    Atzeni, F
    Sarzi-Puttini, P
    Randisi, G
    Marrazza, MG
    Carrabba, M
    Capsoni, F
    THROMBOSIS RESEARCH, 2004, 114 (5-6) : 642 - 642
12345